Flemming Ornskov, the former chief of Shire PLC, which was absorbed this year by Takeda Pharmaceutical Co. Ltd., has reappeared as head of Nestle Skin Health SA – newly rebranded as Galderma – with a remit to spearhead and grow the dermatology group’s presence in the US and China.
Ex Shire CEO Ornskov Resurfaces To Lead Skin Group Galderma
A group of investors has bought Nestlé Skin Health, renamed it Galderma to capitalize on its legacy in dermatology and put M&A veteran, former Shire CEO Flemming Ornskov, at its helm.
More from Leadership
More from Scrip
• By
The agency loosened requirements for echocardiograms and removed contraindications for a number of commonly used drugs.
• By
The IL-4/IL-13 inhibitor has been approved in the US as the first targeted therapy in over a decade for chronic itching.
• By
Japanese incubator Ciconia has just started verifying its first drug candidate with a vision of building domestic startups with globally competitive assets.